BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Riverlane

Riverlane logo

Website
https://riverlane.io/
Founded
2017
Patents
8
Publications
6

Technologies

Quantum Theory in Drug Discovery

Riverlane is a University of Cambridge spin-out; developing a quantum simulation engine that will transform how materials, drugs, and catalysis are developed. Using quantum computers to accelerate classical computing, Riverlane is building the next generation in computer-aided design.


Posts Mentioning This Company

14 Companies Using Quantum Theory For Drug Discovery (Including 2 Going Public)

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

Feb. 24, 2024  
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal chemistry, and versatile aspects of drug design. However, MM methods have significant limitations, for example, when used to study electron-based properties within the drug-receptor microenvironment. Quantum mechanical (QM) methods allow …

This Company Makes Quantum Computing Actually Useful

Feb. 24, 2024  
Quantum computing represents a monumental shift in the computational landscape, offering the potential to solve complex problems that are currently beyond the reach of classical computers. The principle behind quantum computing relies on the principles of quantum mechanics, utilizing quantum bits or "qubits" that can represent and store information in …

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

April 27, 2023  
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) therapeutics and vaccines. This collaboration highlights the growing interest in the potential of quantum computing within the life sciences sector.
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

News

  • 2024-08-06
    Riverlane Secures $75M for Quantum Error Correction Technology

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.